Get the Stockscreener App
8.01
4.19%
-0.35
Champions Oncology Inc stock is traded at $8.01, with a volume of 19,826.
It is down -4.19% in the last 24 hours and down -4.64% over the past month.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
See More
Previous Close:
$8.36
Open:
$8.16
24h Volume:
19,826
Relative Volume:
0.63
Market Cap:
$110.75M
Revenue:
$49.98M
Net Income/Loss:
$-9.64M
P/E Ratio:
-11.28
EPS:
-0.71
Net Cash Flow:
$-4.86M
1W Performance:
-1.11%
1M Performance:
-4.64%
6M Performance:
-18.10%
1Y Performance:
+62.80%
1-Day Range:
$7.8204
$8.22
1-Week Range:
$7.5923
$8.63
52-Week Range:
$3.6001
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
Name
Champions Oncology Inc
Sector
Industry
Phone
410-369-0365
Address
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
8.01 | 112.00M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.81 | 120.40B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.52 | 61.30B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.53 | 41.06B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
564.59 | 34.29B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.55 | 27.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-18-19 | Initiated | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Stock (CSBR) Latest News
Champions Oncology Inc. Stock Analysis and ForecastMarket-beating performance - Jammu Links News
Hygiene Limited (MHHL)High-velocity gains - Jammu Links News
What drives First National Corporation stock priceAccelerated capital growth - Jammu Links News
What analysts say about Champions Oncology Inc. stockFree Market Volatility Navigation Tips - Jammu Links News
Jagjanani Textiles Limited (532825) Stock RalliesOutstanding capital appreciation - Jammu Links News
Best Stocks for Dividend Growth in India Professional Stock RecommendationsOverwhelming profit margins - Jammu Links News
Top Tech Stocks for Investment Professional Stock RecommendationsBreakthrough profit margins - Jammu Links News
Humanized Mouse and Rat Model Market worth US$409.8 million in 2030 with 8.2% CAGR - openPR.com
Humanized Mouse And Rat Model Market Worth US$409.8 Million In 2030 With 8.2% CAGR - Barchart.com
Champions Oncology Names New CEO - Contract Pharma
Starteck Finance Limited (STARTECK) Gets Regulatory ApprovalSuperior trading gains - Jammu Links News
Champions Oncology Announces Appointment of New CEO - ACCESS Newswire
Champions Oncology names Rob Brainin as new CEO By Investing.com - Investing.com Canada
Champions Oncology appoints Rob Brainin as CEO - TipRanks
Champions Oncology Taps 25-Year Life Sciences Leader Rob Brainin as CEO for Strategic Data Platform Push - Stock Titan
Patient-Derived Xenograft Model Market Size at USD 1.12 Billion in 2031, Forecasted to Grow at 13.4% CAGR Through 2031 | The Insight Partners - The Malaysian Reserve
Is Sohu.com Limited Depositary Receipt stock a good hedge against inflationLow Risk Stock Strategies - Newser
CARDI(cardi drc 20) Tokenomics ExplainedFree Risk Assessment Services - Newser
Top Reasons to Buy MINIBNBTIGER(minibnbtiger)Top Momentum Stock Pick - Newser
Why FirstSun Capital Bancorp stock attracts strong analyst attentionMassive Upside Selection - Newser
How Champions Oncology Inc. stock performs during market volatilityTriple Digit Return Forecasts - Newser
Why Ring Energy Inc. stock attracts strong analyst attentionFree Access to Community - Newser
What makes Champions Oncology Inc. stock price move sharplyFree Best Performing Stock Alerts - Newser
Why Champions Oncology Inc. stock attracts strong analyst attentionReal Time Stock Signal - Newser
How EBON stock performs during market volatilityRisk Managed Trading Strategy - Newser
How Gladstone Commercial Corporation Preferred Security stock performs during market volatilityTop Rated Trade Entries - Newser
How ZW Data Action Technologies Inc. stock performs during market volatilityDaily Price Surge List - Newser
Why BOB(build on bnb) Will ExplodeCapital Growth Picks - Newser
What makes INKT stock price move sharplyFree Elite Traders Group - Newser
Why ESSA Pharma Inc. stock attracts strong analyst attentionWeekly Double Return List - Newser
How Blackstone Inc. stock performs during market volatilityProfessional Stock Screener - Newser
Why LGMK stock attracts strong analyst attentionConsistent High Return Strategy - Newser
Why High Roller Technologies Inc. stock attracts strong analyst attentionInvestor Friendly Risk Reward - Newser
When UBSI stock expected to show significant growthIs SGRY stock a good long term investment option5x Profit Potential - Newser
How Omega Healthcare Investors Inc. stock performs during market volatilityWeekly Big Movers - Newser
Why Olympic Steel Inc. stock attracts strong analyst attentionSafety First Trading Signals - Newser
How Gilead Sciences Inc. stock performs during market volatilityFree Stock Market Knowledge Sharing - Newser
What makes Superior Group of Companies Inc. stock price move sharplyFree Stock Trading Community - Newser
Why SONDW stock attracts strong analyst attentionHigh Return Intraday Picks - Newser
How OTIS stock performs during market volatilityLong Term Safe Yield Focus - Newser
AGFA HealthCare Achieves HITRUST I1 Certification, Demonstrating Its Commitment to and Compliance With Data Protection Standards, and Protecting Against Cybersecurity Threats - NTB Kommunikasjon
Press-Releases - Western Morning News
Colorectal Cancer Treatment Market Size is Projected to Reach USD 24.77 Billion, with a Robust 3.2% CAGR till 2031, Rising Prevalence of Cancer Boosts | The Insight Partners - The Malaysian Reserve
Champions oncology launches radiopharmaceutical services platform By Investing.com - Investing.com Canada
Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models - ACCESS Newswire
Champions Oncology Launches Advanced Radiopharmaceutical Platform with 30+ PDX Models | CSBR Stock News - Stock Titan
Champions Oncology, Inc.'s (NASDAQ:CSBR) Shares Leap 29% Yet They're Still Not Telling The Full Story - simplywall.st
Polaris Renewable Energy Announces Q1 2025 Investor Call Details - Via Ritzau
Unlocking a First-in-Class EGFR/HER3 ADC: Sichuan Biokin's Iza-Bren Poised to Transform Oncology Markets - AInvest
(CSBR) Trading Advice - news.stocktradersdaily.com
Merus N.V. (MRUS): A Breakthrough in Oncology with Petosemtamab's ASCO-Backed Potential - AInvest
Champions Oncology Inc Stock (CSBR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):